- Home
- GENK vs TNON Comparison
GENK vs TNON Comparison
Compare GENK & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENK | TNON |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | 2700 | 27 |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 7.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GENK | TNON |
|---|---|---|
| Price | $1.54 | $0.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | 47.0K | ★ 86.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 62.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $208,380,000.00 | N/A |
| Revenue This Year | $15.02 | $65.95 |
| Revenue Next Year | N/A | $50.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.12 | N/A |
| 52 Week Low | $1.43 | $0.64 |
| 52 Week High | $4.98 | $2.48 |
Technical Indicators
Market Signals| Indicator | GENK | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 50.64 |
| Support Level | $1.46 | $0.66 |
| Resistance Level | $2.55 | $0.88 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 28.95 | 52.14 |
Price Performance
Historical ComparisonAbout GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.